InnoSkel Archives | Be Korea-savvy
Home / Posts tagged InnoSkel
InnoSkel Awarded Innovation Passport by the UK MHRA for the Treatment of a Rare Bone Disorder

InnoSkel Awarded Innovation Passport by the UK MHRA for the Treatment of a Rare Bone Disorder

Nice, France, Dec. 16 (Korea Bizwire) – InnoSkel (the “Company”), a pioneering biotechnology company developing transformative therapies for the unmet needs of individuals with rare bone disorders, today announced that it has been awarded an Innovation Passport under the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) Innovative Licensing and Access Pathway (ILAP), to pursue accelerated patient access [...]

Jeito Capital Leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders

Jeito Capital Leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders

Paris, France, Dec. 14 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announces that it has led a €20 million Series A financing in InnoSkel, a newly launched pioneering platform biotechnology company developing therapies for rare and life-threatening skeletal diseases. Jeito co-led the financing in a [...]

InnoSkel Launches with €20 Million Series A Financing

InnoSkel Launches with €20 Million Series A Financing

Nice, France, Dec. 14 (Korea Bizwire) – InnoSkel, a newly launched platform biotechnology company pioneering gene therapies for rare skeletal diseases, today announced that it has raised €20 million in a Series A financing round. The fundraise was co-led by Jeito Capital and Vida Ventures, with additional support from Turenne Group and Région Sud Investissement. Proceeds [...]